Compare BKD & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BKD | TMDX |
|---|---|---|
| Founded | 2005 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.6B |
| IPO Year | 2005 | 2019 |
| Metric | BKD | TMDX |
|---|---|---|
| Price | $12.13 | $86.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $15.10 | ★ $148.22 |
| AVG Volume (30 Days) | ★ 4.8M | 589.9K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | 0.07 | ★ 0.61 |
| Revenue | ★ $4,531,426,000.00 | $605,494,000.00 |
| Revenue This Year | N/A | $24.25 |
| Revenue Next Year | $4.30 | $18.75 |
| P/E Ratio | $172.71 | ★ $144.70 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $7.29 | $60.11 |
| 52 Week High | $17.09 | $156.00 |
| Indicator | BKD | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 40.73 | 49.23 |
| Support Level | $11.64 | $81.34 |
| Resistance Level | $14.36 | $95.18 |
| Average True Range (ATR) | 0.37 | 3.84 |
| MACD | 0.09 | -0.95 |
| Stochastic Oscillator | 65.62 | 32.08 |
Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.